Biomechanics/Motion Analysis Laboratory Data Bank

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Oct 2026 to Oct 2027v29
  2. Primary and study completion dates: Oct 2025 to Oct 2026v28
  3. Re-verified, no change to tracked fieldsv27
  4. Primary and study completion dates: Oct 2024 to Oct 2025
    • Site contact updated
    v26
  5. Primary and study completion dates: Dec 2021 to Oct 2024v25
Show 23 earlier versionsHide 23 earlier versions
  1. Re-verified, no change to tracked fieldsv24
  2. Primary and study completion dates: Jan 2020 to Dec 2021v23
  3. 8 versions Re-verified since Apr 21, 2014, no change to tracked fieldsv15-v22
  4. Interventions: joint motion analysis (Behavioral) to Joint Motion Analysis (Behavioral)
    • Site contact updated
    • Study arms: 0 to 1
    v14
  5. Site contact updatedv13
  6. Site contact updatedv12
  7. 3 versions Re-verified since Oct 14, 2010, no change to tracked fieldsv9-v11
  8. Enrollment target: 10000
    • Primary and study completion dates: Jan 2020
    • Eligibility criteria expanded, about 25 words
    v8
  9. Study description expanded, about 24 words
    • Site contact updated
    v7
  10. Site contact updatedv6
  11. 3 versions Re-verified since Sep 25, 2006, no change to tracked fieldsv3-v5
  12. Eligibility criteria shortened, about 3 words
    • Study title expanded, about 1 word
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the data bank is to collect data on joint motion.
Trial Details
NCT Number NCT00160771
Lead Sponsor University of Florida
Conditions
(from sponsor)		 Kinematics
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov